Captis Pharmacy Breakout: Maximize Your Financial and Operational Value
The Captis Pharmacy Breakout features three separate sessions with speaker panels representing Captis Pharmacy members, health-system pharmacy leaders, and the pharmacy supplier community. Content will focus on navigating the current challenges and opportunities related to: biosimilar integration, drug shortages, and the Inflation Reduction Act.
Target Audience
- Healthcare Executives
- Pharmacists
- Pharmacy Technicians
- Other Healthcare Professionals
Learning Objectives
Pharmacists
At the conclusion of this activity, pharmacists should be able to:
- Discuss the financial challenges and external forces health systems face with integrating biosimilars into existing frameworks.
- Identify key operational barriers to the adoption of biosimilars with different health systems.
- Gain insights into the dynamics influencing biosimilar integration from a supplier perspective.
- Examine the market opportunities presented by biosimilars and their potential impact within health systems including patients, providers, suppliers, and payers.
- Define the key provisions and goals of the Inflation Reduction Act
- Analyze the potential benefits of the Inflation Reduction Act in stabilizing prices and fostering economic growth
- Evaluate the potential drawbacks or challenges associated with implementing the Inflation Reduction Act
- Facilitate informed discussions on the potential trade-offs and considerations involved in enacting the Inflation Reduction Act
- Describe the current landscape of drug shortages highlight specific challenges
- Assess the consequences of drug shortages on patient outcomes and healthcare professionals
- Provide insight on successful strategies to mitigate the impact of drug shortages
Pharmacy Technicians
At the conclusion of this activity, pharmacy technicians should be able to:
- Discuss the financial challenges and external forces health systems face with integrating biosimilars into existing frameworks.
- Identify key operational barriers to the adoption of biosimilars with different health systems.
- Gain insights into the dynamics influencing biosimilar integration from a supplier perspective.
- Examine the market opportunities presented by biosimilars and their potential impact within health systems including patients, providers, suppliers, and payers.
- Define the key provisions and goals of the Inflation Reduction Act
- Analyze the potential benefits of the Inflation Reduction Act in stabilizing prices and fostering economic growth
- Evaluate the potential drawbacks or challenges associated with implementing the Inflation Reduction Act
- Facilitate informed discussions on the potential trade-offs and considerations involved in enacting the Inflation Reduction Act
- Describe the current landscape of drug shortages highlight specific challenges
- Assess the consequences of drug shortages on patient outcomes and healthcare professionals
- Provide insight on successful strategies to mitigate the impact of drug shortages
FACULTY & PLANNERS
Wendy Biese, PharmD, MBA, DPLA
Director, Pharmacy
ThedaCare, Inc.
Sara J. Erickson, PharmD
Senior Pharmacy Specialist
Mayo Clinic
Adam Ewald, PharmD, MHA
Sr. Pharmaceutical Contract Portfolio Manager
Mayo Clinic
Matthew Flink, MBA
Director, Pharmacy Administration
Endeavor Health
Mary Gilmer, PharmD, MHA, BCPS
Director of Pharmaceutical Procurement and Supply
Mayo Clinic
Michelle Holm, PharmD, MHA, BCPS
Senior Pharmaceutical Contract Portfolio Manager
Mayo Clinic
Nate Leedahl, PharmD, BCPS
Manager, Health System Pharmacy
Sanford Health
Robert Lucas, PharmD, MBA, BCPS, FASHP
Director of Pharmacy
Blount Memorial Hospital
Lauren Neves, JD
Vice President, Policy and Research
PhRMA
James Semrad
Vice President Service Line Growth/Strategy& Pharmacy
ProHealth Care
Jenna Stern, JD
AVP, Regulatory Affairs and Public Policy
Vizient, Inc.
Cos Trifonidis, MBA
Director, US Biosimilars- IDN/Hospital/Federal Strategy
Organon
Planning Committee
Andy Hart, PharmD, RPh
Pharmacy Executive
Captis | Strategic Sourcing Partnerships and Programs
Vizient, Inc.
Samantha Gordon, MS
CE Programs Manager
Vizient, Inc.
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education
Vizient, Inc.
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s)
Pharmacists (CPE)
Available Credit
- 2.25 ACPE Pharmacist
- 2.25 ACPE Pharmacy Technician
- 2.25 General CE - Attendance
- If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
- This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Required Hardware/software
The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.